#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	25670	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2021	1246.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	1475	C	1423	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	25670	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2021	1246.3	0	HET	.	.	.	C1269T,G	.	1269	1269	C	1501	1501	C	1535	C,T,G	1138,337,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46826	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3517	1316.1	0	.	n	.	0	T695C	SNP	695	695	T	1002	1002	C	1431	C	1379	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46826	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3517	1316.1	0	.	n	.	0	C1005T	SNP	1005	1005	C	1312	1312	T	1500	T,C	1447,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46826	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3517	1316.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1644	1644	A	1579	A,G	1526,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46826	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3517	1316.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2278	2278	C	1504	C,T	1444,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46826	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3517	1316.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2352	2352	A	1459	A	1411	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46826	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3517	1316.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2904	2904	C	1432	C,A	1392,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	3380	folP	855	855	100.0	folP.l15.c17.ctg.1	1452	229.4	1	SNP	p	R229S	1	.	.	685	687	AGC	930	932	AGC	343;344;345	A,C;G;C	334,1;338;336	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	9606	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3297	287.8	1	SNP	p	S91F	1	.	.	271	273	TTC	540	542	TTC	346;347;350	T,C;T;C	334,1;332;333	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	9606	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3297	287.8	1	SNP	p	G95N	0	.	.	283	285	GGC	552	554	GGC	330;330;325	G;G;C,A	314;315;307,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	9606	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3297	287.8	1	SNP	p	D95G	1	.	.	283	285	GGC	552	554	GGC	330;330;325	G;G;C,A	314;315;307,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2852	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1326	212.2	1	SNP	p	G45D	0	.	.	133	135	GGC	499	501	GGC	339;338;335	G;G;C	332;331;324	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1524	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1023	147.6	0	.	n	.	0	A197.	DEL	197	197	A	544	544	A	343	A	335	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	276.7	1	SNP	p	D86N	0	.	.	256	258	GAC	560	562	GAC	336;338;340	G;A,T,C;C	331;322,2,1;335	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	276.7	1	SNP	p	R87I	0	.	.	259	261	CGT	563	565	CGT	342;344;345	C;G;T	336;336;338	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	276.7	1	SNP	p	R87W	0	.	.	259	261	CGT	563	565	CGT	342;344;345	C;G;T	336;336;338	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	276.7	1	SNP	p	S87R	1	.	.	259	261	CGT	563	565	CGT	342;344;345	C;G;T	336;336;338	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	276.7	1	SNP	p	S88P	0	.	.	262	264	TCC	566	568	TCC	346;347;348	T;C,A;C	337;341,1;342	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	7006	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2650	261.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1506	1508	GGC	318;310;311	G;G;C,G	306;299;296,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1263	1265	GCA	395;400;402	G,C,A;C,A;A	377,1,1;375,2;388	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1266	1268	ATC	404;404;405	A;T;C	390;383;382	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1278	1280	GTG	395;394;393	G;T;G	381;374;379	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1278	1280	GTG	395;394;393	G;T;G	381;374;379	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1782	1784	ACC	318;319;317	A;C;C	298;306;301	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1836	1838	GCG	283;279;282	G;C,G;G,A,C	264;235,3;255,1,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1836	1838	GCG	283;279;282	G;C,G;G,A,C	264;235,3;255,1,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1959	1961	AGC	271;269;267	A;G;C	261;261;255	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1968	1970	GGC	260;255;253	G;G;C	247;242;241	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6572	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2368	273.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1986	1988	CCG	213;215;217	C,G;C,G,A;G	177,3;179,3,1;186	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	9914	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3056	320.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1625	1627	CCG	333;339;339	C;C;G	311;329;313	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4224	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1838	226.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	525	525	C	289	C	273	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	377	379	GAA	414;415;416	G;A;A	398;403;403	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	K120R	NONSYN	358	360	AAG	623	625	AGG	379;373;376	A;G;G	365;358;364	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	665	667	GAT	361;364;366	G,A;A;T	354,1;357;357	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	788	790	TCA	352;352;355	T;C;A	341;339;343	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	A218I	NONSYN	652	654	GCC	917	919	ATC	357;356;355	A;T;C	343;339;341	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	929	931	TCT	353;354;349	T;C,T;T	343;347,1;345	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1247	1249	GCA	354;351;346	G;C;A	341;341;335	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	1	SNP	p	D121N	0	.	.	361	363	GAC	626	628	GAC	375;370;370	G;A;C	362;356;357	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4560	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1616	277.6	1	SNP	p	A121D	1	.	.	361	363	GAC	626	628	GAC	375;370;370	G;A;C	362;356;357	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	15658	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4771	324.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1866	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1084	169.6	1	SNP	p	V57M	1	.	.	169	171	ATG	522	524	ATG	375;375;373	A;T;G	368;368;368	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
